[The distribution and effects of fluoracizine in rats administered by different routes].
D000284:Administration, Oral; D000409:Alanine / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism; D002375:Catalepsy / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D008099:Liver / Q000378:metabolism; D008297:Male; D010640:Phenothiazines / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D013747:Tetrabenazine / Q000037:antagonists & inhibitors
D006845:Hydrocarbons, Fluorinated; D010640:Phenothiazines; D000409:Alanine; D013747:Tetrabenazine
Osobennosti raspredeleniia i deĭstviia ftoratsizina u krys pri raznykh putiakh ego vvedniia.